THE BURDEN ASSOCIATED WITH IMMUNOGLOBULIN A NEPHROPATHY(IGAN)

被引：0
|
作者：
George, A. T. [1 ]
Zaour, N. [2 ]
Lochlainn, Nic E. M. [2 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Hyderabad, India
[2] Novartis Pharma AG, Basel, Switzerland
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK31
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 50 条
  • [1] Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
    De Angelis, Maria
    Montemurno, Eustacchio
    Piccolo, Maria
    Vannini, Lucia
    Lauriero, Gabriella
    Maranzano, Valentina
    Gozzi, Giorgia
    Serrazanetti, Diana
    Dalfino, Giuseppe
    Gobbetti, Marco
    Gesualdo, Loreto
    [J]. PLOS ONE, 2014, 9 (06):
  • [2] SALIVARY MICROBIOTA ASSOCIATED WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN)
    Montemurno, Eustacchio
    De Angelis, Maria
    Piccolo, Maria
    Lauriero, Gabriella
    Gobbetti, Marco
    Gesualdo, Loreto
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [3] THE LIFE-LONG ECONOMIC BURDEN OF IMMUNOGLOBULIN A NEPHROPATHY (IGAN) IN CHINA
    Xiao, D.
    Du, X.
    Ao, C.
    Zhang, Y.
    Xuan, J.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S45 - S45
  • [4] Epidemiology of immunoglobulin A nephropathy (IgAN) in Germany
    Roll, Matthias
    Gladbach, Amadeus
    Selinger, Isabella
    Hardt, Thomas
    Himmelhaus, Helena
    Jacob, Christian
    Stremel, Timotheus
    Theil, Julia
    Floege, Juergen
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I689 - I690
  • [5] Symptom Burden Among Immunoglobulin A Nephropathy (IgAN) Patients in a US Real-World Setting
    Perkins, Robert M.
    Aldworth, Carolina A.
    Przybysz, Raymond
    Doherty, Jim P.
    Olson, Stephen W.
    George, Aneesh T.
    Das, Jaydeep
    Studer, Rachel
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 494 - 495
  • [6] Health State Utility Values for Immunoglobulin A Nephropathy (IgAN)
    Zhou, Mo
    Bensink, Mark E.
    Hazra, Nisha C.
    Xu, Chunyi
    Hendry, Bruce M.
    Sharpe, Claire C.
    Zhou, Zheng-Yi
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 187 - 187
  • [7] SYSTEMATIC REVIEW ON COST AND HEALTHCARE RESOURCE UTILIZATION IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN)
    Doherty, J.
    George, K.
    Akkapantula, S.
    Kolli, N. R.
    Pannagl, K.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S183 - S183
  • [8] Clinical and immunohistochemical study of immunoglobulin A nephropathy (IgAN) before and after tonsillectomy
    Abe, K
    Miyazaki, M
    Shioshita, K
    Harada, T
    Koji, T
    Kohno, S
    [J]. ACTA OTO-LARYNGOLOGICA, 2004, 124 : 20 - 24
  • [9] PATIENT INSIGHTS FOR IMMUNOGLOBULIN A NEPHROPATHY (IGAN) USING SOCIAL MEDIA LISTENING
    Tyagi, N.
    Aasaithambi, S.
    Chauhan, J.
    George, A.
    Zaour, N.
    [J]. VALUE IN HEALTH, 2019, 22 : S919 - S919
  • [10] Enhancing immunoglobulin A nephropathy management: insights from the IGAN-MIC project
    Jiang, Gengru
    Chen, Qinkai
    Zhang, Qinghong
    Tean, M. A.
    Chen, Chaosheng
    Bi, Guangyu
    Xing, Changying
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2041 - I2042
12345